$RLX

RLX Technology Inc. (RLX): Financial results for Q2 2026

RLX Technology Inc. (RLX) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 RLX Technology Announces Unaudited Second Quarter 2026 Financial Results SHENZHEN, August 14, 2026 /PRNEWSWIRE/ - RLX Technology Inc. ("RLX Technology" or the "Company") (NYSE: RLX), a leading global branded e-vapor company, today announced its unaudited financial re

Original reporting
Published Aug 14, 2026, 10:56 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 28, 2026, 6:23 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$RLX
Bullish
high confidence
Mentioned
$RLX
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 6-K
Decision brief

The 30-second read

$RLXBullishMed
01

Why it matters

The earnings release provides fresh quantitative data on growth and profitability, offering traders a basis for short‑term positioning.

02

Market read

First‑hand earnings data for a mid‑cap growth company; potential catalyst for price movement.

03

What to watch

Cash balance decline and modest operating cash burn suggest capital efficiency needs monitoring.

Relevance 7/10Novelty 7/10Timing: after‑hours release on Aug 14
AlphAI · Earnings readRLX · Q2 2026 · ended June 30, 2026

RLX Technology reported second-quarter net revenues of RMB1,010.5 million, up 14.8% year over year, while gross margin expanded to 35.4% from 27.5%.

Solid quarter

Revenue growth, a 47.8% increase in gross profit, and substantial gross-margin expansion supported solid operating results. Non-GAAP net income declined from the prior year, operating cash flow was negative, and management said revenue and gross profit moderated from the first quarter because Q1 included a one-time export-regulation benefit.

Revenue
RMB1,010.5 million
14.8% y/y
Gross margin · GAAP
35.4%

Key metrics

as reported
MetricValueq/qy/y
Total net revenuesGAAPRMB1,010.5 million (US$148.9 million)14.8%
International business revenue mixother68.5% of net revenues
Cost of revenuesGAAPRMB559,057 thousand (US$82,395 thousand)
Excise tax on productsGAAPRMB93,563 thousand (US$13,790 thousand)
Gross profitGAAPRMB357.8 million (US$52.7 million)47.8%
Gross marginGAAP35.4%
Selling expensesGAAPRMB123.7 million (US$18.2 million)
General and administrative expensesGAAPRMB74.4 million (US$11.0 million)
Research and development expensesGAAPRMB29.4 million (US$4.3 million)
Total operating expensesGAAPRMB227.5 million (US$33.5 million)
Income from operationsGAAPRMB130.4 million (US$19.2 million)234.7%
Income from operationsnon-GAAPRMB149.6 million (US$22.0 million)28.8%
Interest income, netGAAPRMB109,116 thousand (US$16,082 thousand)
Investment incomeGAAPRMB7,117 thousand (US$1,049 thousand)
Others, netGAAPRMB235 thousand (US$35 thousand)
Income before income taxGAAPRMB246,849 thousand (US$36,381 thousand)
Income tax expenseGAAPRMB24.8 million (US$3.7 million)
Net incomeGAAPRMB222.0 million (US$32.7 million)1.6%
Net incomenon-GAAPRMB238.8 million (US$35.2 million)
Net income attributable to RLX Technology Inc.GAAPRMB217,746 thousand (US$32,092 thousand)
Basic net income per ADSGAAPRMB0.178 (US$0.026)
Diluted net income per ADSGAAPRMB0.167 (US$0.025)
Basic net income per ADSnon-GAAPRMB0.190 (US$0.028)
Diluted net income per ADSnon-GAAPRMB0.178 (US$0.026)
Total comprehensive incomeGAAPRMB43,713 thousand (US$6,443 thousand)
Net cash used in operating activitiesGAAPRMB63.2 million (US$9.3 million)
Net cash generated from investing activitiesGAAPRMB983,338 thousand (US$144,926 thousand)
Net cash used in financing activitiesGAAPRMB403,599 thousand (US$59,483 thousand)

What drove it

  • Net-revenue growth was primarily due to international expansion and contributions from the Company’s May 2025 acquisition.
  • Gross-margin expansion was primarily due to a favorable change in revenue mix and further supply chain optimization.
  • Selling expenses increased primarily due to salary and welfare expenses, branding expenses, and depreciation and amortization expenses related to the May 2025 acquisition.
  • General and administrative and research and development expenses benefited from lower share-based compensation expenses.
  • In July 2026, RLX acquired a 51% equity interest and board control in a Western European distributor of next-generation smoke-free and FMCG products. The entity’s results will be consolidated beginning in the third quarter of 2026.

Concerns

  • Management said second-quarter revenues and gross profit moderated from the first quarter, which included a disclosed one-time benefit due to a change of export related regulation.
  • Non-GAAP net income was RMB238.8 million, compared with RMB291.2 million in the same period of 2025.
  • Net cash used in operating activities was RMB63.2 million (US$9.3 million).
  • Foreign currency translation adjustments were RMB(181,016) thousand (US$26,678 thousand), contributing to total comprehensive income of RMB43,713 thousand (US$6,443 thousand).

What to watch

  • Consolidation of the July 2026 Western European distributor acquisition beginning in the third quarter of 2026.
  • Execution of the European dual-engine approach, including strategic investment in top-tier local partners and organic growth.
  • Store-level execution in Asia and expansion of modern oral nicotine pouches and other smokeless categories.
  • Whether gross-margin benefits from revenue mix and supply-chain optimization continue after the first-quarter export-regulation benefit.

Balance sheet and cash flow

  • Cash and cash equivalents, restricted cash, short-term bank deposits, net, short-term investments, long-term bank deposits, net, and long-term investment securities, net were RMB13,883.4 million (US$2,046.2 million) as of June 30, 2026, compared with RMB14,529.7 million as of March 31, 2026.
  • Cash and cash equivalents were RMB4,629,116 thousand (US$682,247 thousand) as of June 30, 2026, compared with RMB5,367,139 thousand as of December 31, 2025.
  • Short-term investments were RMB2,019,812 thousand (US$297,683 thousand) as of June 30, 2026, compared with RMB2,326,610 thousand as of December 31, 2025.
  • Long-term bank deposits, net were RMB526,412 thousand (US$77,584 thousand) as of June 30, 2026, compared with RMB433,618 thousand as of December 31, 2025.
  • Long-term investment securities, net were RMB4,387,136 thousand (US$646,584 thousand) as of June 30, 2026, compared with RMB5,116,336 thousand as of December 31, 2025.
  • Short-term loan was RMB165,168 thousand (US$24,343 thousand) as of June 30, 2026, compared with RMB92,100 thousand as of December 31, 2025.
  • Cash, cash equivalents and restricted cash at the end of the period were RMB4,839,991 thousand (US$713,326 thousand).

Analysis

RLX reported RMB1,010.5 million of second-quarter net revenues, up 14.8% from RMB880.0 million in the same period of 2025. The company attributed growth to international expansion and contributions from its May 2025 acquisition, while international business accounted for 68.5% of revenue. Management stated that revenue moderated from the first quarter, which included a disclosed one-time benefit from a change of export related regulation.

Gross profit rose 47.8% to RMB357.8 million and gross margin expanded to 35.4% from 27.5%. RLX attributed the margin improvement to a favorable change in revenue mix and further supply chain optimization. This gross-profit growth exceeded revenue growth and supported U.S. GAAP income from operations of RMB130.4 million, up 234.7% year over year, and non-GAAP income from operations of RMB149.6 million, up 28.8%.

Operating expenses were RMB227.5 million compared with RMB203.1 million in the prior-year period. Selling expenses increased to RMB123.7 million from RMB84.6 million, reflecting salary and welfare, branding, and acquisition-related depreciation and amortization expenses. General and administrative expenses declined to RMB74.4 million from RMB88.4 million and research and development expenses declined to RMB29.4 million from RMB30.1 million, each primarily reflecting lower share-based compensation expenses. U.S. GAAP net income increased 1.6% to RMB222.0 million, while non-GAAP net income declined to RMB238.8 million from RMB291.2 million.

Liquidity remained substantial, with the stated aggregate of cash, restricted cash, bank deposits, and investments at RMB13,883.4 million as of June 30, 2026, versus RMB14,529.7 million as of March 31, 2026. Second-quarter operating cash flow was negative RMB63.2 million and financing cash outflow was RMB403.6 million. In July 2026, RLX acquired a 51% equity interest and board control in a Western European distributor; its financial results will be consolidated beginning in the third quarter. The release provided no quantitative financial outlook.

Management, verbatim

We delivered solid second quarter results as we continued to strengthen our global business with a focus on quality, stability, and long-term resilience.

Ying (Kate) Wang, Co-founder, Chairperson, and Chief Executive Officer of RLX Technology

As expected, revenues and gross profit moderated from the first quarter, which included a disclosed one-time benefit due to the change of export related regulation.

Chao Lu, Chief Financial Officer of RLX Technology

Not in the filing

stated, not guessed
  • Forward revenue, gross-margin, operating-expense, tax-rate, earnings, or cash-flow guidance
  • Prior outlook for comparison
  • Segment revenue and segment profitability disclosures
  • Free cash flow
  • Share repurchases
  • Dividend declaration or payment details for the reported quarter
  • Total debt
  • Tax rate
  • Purchase consideration for the July 2026 acquisition
  • Quantified financial contribution expected from the July 2026 acquisition

AlphAI analysis generated from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure was cross-checked against the filing text; consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Background

RLX Technology is a NYSE‑listed e‑vapor company expanding into smoke‑free oral nicotine products.

Company-level read

Ticker impact

$RLXBullishHigh confidence
Context

RLX Technology reported Q2 2026 results with 14.8% revenue growth, gross margin up to 35.4% and a 28.8% rise in non‑GAAP operating income.

Expected impact

Modest upside as investors price higher margins and growth outlook.

Evidence & confidence

The combination of double‑digit revenue growth, margin expansion and strategic acquisition provides a clear catalyst for a short‑term price rally.

Market effects

Strengthens the e‑vapor and broader smoke‑free product sector, highlighting demand for premium distribution networks.

European market sees potential upside from the new 51% stake in a major distributor.

Adds to the narrative of growth in alternative nicotine products worldwide.

Counterpoint

Margin gains may be temporary if input costs rise; acquisition integration risk could pressure near‑term earnings.

Key entities

  • RLX Technology Inc.

    Subject of the earnings release.

  • Western European distributor (51% stake)

    Acquired asset expanding RLX's European footprint.

Every RLX earnings report

This story covers one filing. The ticker page keeps them all: each quarter's reported metrics with year-over-year and sequential comparisons, segments, guidance, and how the numbers landed against the company's own prior outlook.

Related articles

$RLXMed

RLX Technology (RLX) Bets Big On Europe And Nicotine Pouches

RLX Technology (RLX) reported Q2 2026 revenue of RMB1.01B (+14.8% YoY), with international sales at 70% of revenue. Gross margin expanded to 35.4% due to supply chain and product mix improvements. The company acquired a 51% stake in a European distributor, aiming to build direct retail relationships. However, China revenue is expected to be flat for the year due to regulatory tightening. RLX is also investing in nicotine pouches and has RMB13.9B in capital resources.

$RLXMedAI 8/10

RLX Technology (RLX) Q2 2026 Earnings Call Transcript

RLX Technology reported Q2 2026 net revenue of RMB 1,010.5 million, up 14.8% YoY, driven by international expansion and a 2025 acquisition. Gross margin expanded to 35.4% from 27.5% YoY. International sales contributed 70% of revenue. Non-GAAP income from operations rose 28.8% YoY to RMB 149.6 million. GAAP net income increased 1.6% YoY to RMB 222.0 million. Management highlighted growth in oral nicotine pouches and a 51% investment in a European distributor.

$RLXMedAI 8/10

Robust Earnings and International Expansion Assert RLX Technology Inc. (RLX) as a Top Sin Stock to Buy

RLX Technology (NYSE:RLX) reported first-quarter results on May 20 that beat expectations, driven by international expansion. Net revenues rose 96.2% to $229.9 million and gross margin improved to 31.8% from 28.6%. Adjusted net income increased 41.4% to $51.8 million, with adjusted EPS of $0.038. International operations were 72.3% of revenue, led by Europe and Asia.

$IPHAMed

Innate Pharma (IPHA) Q2 2026 Earnings Call Transcript

Innate Pharma (IPHA) reported Q2 2026 earnings, highlighting a cash position of -€21.4M, a $75M upfront payment from Sobi, and -€28M in net equity proceeds. H1 2026 net loss was -€19.6M, with revenue of -€5.7M. The company extended its cash runway to Q1 2028 and anticipates key milestones, including a Phase 3 readout for monalizumab and initial data for IPH4502. Management expects to file for accelerated approval of lacutamab in Sezary Syndrome in H2 2027.

$UPXIMed

Upexi Inc (UPXI) (Q4 2026) Earnings Call Highlights: Massive Solana Treasury Fuels $246

Upexi Inc. (UPXI) reported Q4 2026 earnings, highlighting a $246M net loss driven by digital asset losses. CEO Alan Marshall discussed Solana treasury management, debt restructuring, and cost-cutting efforts. The company holds 2.34M Solana tokens, with staking revenue covering expenses. Management emphasized creative capital allocation and potential expansion in Asian markets through the Hivemind partnership. Stockholders' equity was negative $53.8M as of June 30, 2026.